In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Tenax Therapeutics, with a price target of $35.00.TipRa...

In a report released today, Patrick Dolezal from LifeSci Capital maintained a Buy rating on Neurogene, with a price target of $65.00.TipRanks We...

LifeSci Capital analyst Cory Jubinville, PhD maintained a Buy rating on Prime Medicine, Inc. today and set a price target of $6.00.TipRanks Welc...

In a report released today, Gaurav Maini from LifeSci Capital maintained a Buy rating on Tenax Therapeutics, with a price target of $35.00.TipRa...